Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option?

Canellos GP.

Oncologist. 2009 Dec;14(12):1167-8. doi: 10.1634/theoncologist.2009-0288. Epub 2009 Dec 11. No abstract available.

2.

Advances in the treatment of Hodgkin's disease.

Santoro A, Valagussa P.

Curr Opin Oncol. 1992 Oct;4(5):821-8. Review.

PMID:
1457496
3.

New therapies in Hodgkin's lymphoma.

Bartlett N.

Clin Adv Hematol Oncol. 2004 Feb;2(2):80, 83. No abstract available.

PMID:
16163165
4.

The case for chemotherapy only for localized Hodgkin lymphoma.

Straus DJ.

Oncologist. 2009 Dec;14(12):1225-31. doi: 10.1634/theoncologist.2009-0129. Epub 2009 Dec 10. Review.

5.

Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.

Canellos GP.

J Clin Oncol. 2005 Jul 20;23(21):4574-6. Epub 2005 Apr 18. No abstract available.

PMID:
15837972
6.

[Therapy of recurrent Hodgkin's lymphoma. I. Radiotherapy and conventional chemotherapy].

Pfreundschuh M, Diehl V.

Dtsch Med Wochenschr. 1989 Jun 2;114(22):880-4. Review. German. No abstract available.

PMID:
2656184
7.

Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma.

Skarbnik AP, Pro B.

Expert Rev Hematol. 2013 Feb;6(1):1-3. doi: 10.1586/ehm.12.71. Review. No abstract available.

PMID:
23373773
8.

The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Laport GF, Williams SF.

Semin Oncol. 1998 Aug;25(4):503-17. Review.

PMID:
9728600
9.

[The choice of second-line chemotherapy for malignant lymphoma].

Ikeda T, Hotta T.

Gan To Kagaku Ryoho. 2005 Jan;32(1):6-10. Japanese.

PMID:
15675573
10.

Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.

David KA, Mauro L, Evens AM.

Curr Treat Options Oncol. 2007 Oct;8(5):352-74. doi: 10.1007/s11864-007-0046-9. Review.

PMID:
18214690
11.

[Lymphoma].

Mohar A, Sobrevilla-Calvo P, Velasquez WS.

Rev Invest Clin. 1997 May;49 Suppl 1:56-63. Review. Spanish. No abstract available.

PMID:
9380990
12.

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4. Chinese.

PMID:
19102946
13.

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.

Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098.

PMID:
18443961
14.

Therapeutic options for early stage Hopkins disease: an embarrassment of riches or a snake in the grass?

Terpenning M, Werner-Wasik M, Bolin RB.

Semin Oncol. 1997 Feb;24(1):xix-xx, xxiii-xxiv, xxvi-xxx. No abstract available.

PMID:
9045294
15.

[Progress in therapeutic strategy for malignant lymphoma].

Ogura M.

Gan To Kagaku Ryoho. 2005 Mar;32(3):309-27. Review. Japanese.

PMID:
15791814
16.

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group.

Josting A, Rueffer U, Franklin J, Sieber M, Diehl V, Engert A.

Blood. 2000 Aug 15;96(4):1280-6.

17.

Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.

Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A.

J Clin Oncol. 2007 May 20;25(15):2000-5. Epub 2007 Apr 9.

PMID:
17420510
18.

The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.

Maeda LS, Advani RH.

Curr Opin Oncol. 2009 Sep;21(5):397-400. doi: 10.1097/CCO.0b013e32832f3ca3. Review.

PMID:
19606035
19.

Combined-modality therapy for the treatment of Hodgkin's disease.

Hoppe RT.

Front Radiat Ther Oncol. 1992;26:172-80. Review. No abstract available.

PMID:
1511919
20.

Treatment of early-stage nonbulky Hodgkin lymphoma.

Straus DJ.

Curr Opin Oncol. 2006 Sep;18(5):432-6. Review.

PMID:
16894289

Supplemental Content

Support Center